CD4 and neoplasm: JHU083 increases infiltration of anti‐tumor CD8+ T cells and Th1 T cells and decreases immune suppressive myeloid‐derived suppressor cells, regulatory T cells, and CD4+ Th17 cells in EGFR‐mutated lung tumors.